On Thursday, Shares of Amarin Corporation plc (NASDAQ:AMRN), surged 18.97% to $2.32.
Amarin Corporation, declared that Judge Randolph D. Moss of the federal district court for the District of Columbia has granted Amarin’s motion for summary judgment in the company’s lawsuit against the United States Food and Drug Administration (FDA) seeking an order requiring FDA to recognize five-year, New Chemical Entity (NCE), marketing exclusivity for Vascepa®(icosapent ethyl) capsules.
Amarin believes based on the court’s ruling that Vascepa is entitled to five-year marketing exclusivity starting from FDA’s approval of Vascepa in July 2012, thus extending NCE exclusivity through July 25, 2017. The ruling also confirms that acceptance by FDA of abbreviated new drug applications (“ANDAs”) for generic versions of Vascepa is not permitted until July 2016. The related statutory 30-month stay triggered by patent litigation following generic application resubmissions in July 2016 would then expire in January 2020. An appeal of the court’s decision can be filed within 60 days.
Amarin has multiple patents covering Vascepa that expire in 2030. With this motion granted and FDA’s acceptance of ANDAs not permitted, Amarin plans to move to dismiss pending Vascepa patent litigation in connection with ANDA filings formerly presented.
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product comprises Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
Shares of Huntington Bancshares Incorporated (NASDAQ:HBAN), inclined 0.09% to $11.28, during its last trading session.
Huntington Bancshares, will be participating at the 2015 Deutsche Bank Global Financial Services Investor Conference on June 3, 2015. Mr. Howell “Mac” McCullough, Senior Executive Vice President and CFO, is planned to present to analysts and investors at 10:20 AM ET. Mr. McCullough will talk about business and financial performance and strategies, and the presentation will comprise forward-looking statements.
Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services.
Gold prices were a touch higher on the London spot market Friday, as the market awaited the release of the revised U.S. first quarter gross domestic product data.
Spot gold was up 0.1% at $1,189.69 a troy ounce in morning European trade.
At the end of Thursday’s trade, Shares of Yamana Gold, Inc. (NYSE:AUY), gained 0.28% to $3.61.
Yamana Gold Inc. engages in gold mining and related activities, counting exploration, extraction, processing, and reclamation. The company has precious metal properties and land positions in the Americas.
Finally, Maxim Integrated Products, Inc. (NASDAQ:MXIM), ended its last trade with 0.81% loss, and closed at $34.72.
Maxim Integrated Products, makes it easy to calibrate a consumable medical sensor and to monitor or control unsanitary reuse of medical disposables with the DS28E80 gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory.
Key Advantages
- Manufacturing calibration: OEMs can automatically detect and calibrate sensors and accessories to ensure quality
- Usage tracking: guards against incorrect attachment and warns or prevents unsanitary reuse of consumables
- Embedded identification: embedded 1-Wire protocol provides unalterable 64-bit factory-assigned serial ID which allows for tracking and can prevent usage of unauthorized consumables
- Reprogrammable: 248 bytes of user memory organized in 8-byte blocks
- Permanent write protection: flexible per-block options for use memory
Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide. The company also provides a range of high-frequency process technologies and capabilities for use in custom designs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
